We therefore hypothesized that megakaryocyte progenitors in subsets of MDS patients with thrombocytopenia would elevate expression levels of mitotic genes, including AURKA, AURKB, and PLK1, which in turn would promote cytokinesis/cell cycling rather than endomitosis. Here, AURKB is linked to myelodysplastic syndrome.